278 related articles for article (PubMed ID: 37331637)
1. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
[TBL] [Abstract][Full Text] [Related]
4. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
5. Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway.
Wei S; Ma W; Jiang C; Liu J; Liu J; Zhang B; Li W
Phytother Res; 2023 Sep; 37(9):4196-4209. PubMed ID: 37246409
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of NR4A1 alleviates doxorubicin-induced cardiotoxicity through inhibiting the activation of the NLRP3 inflammasome.
Hu H; Zhong Z; Meng L; Chen J; Yu Z; Lu K
Biochem Biophys Res Commun; 2024 Mar; 700():149582. PubMed ID: 38306930
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
8. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
9. Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome.
Shi W; Chen J; Zhao N; Xing Y; Liu S; Chen M; Fang W; Zhang T; Li L; Zhang H; Zhang M; Zeng X; Chen S; Wang S; Xie S; Deng W
J Mol Cell Cardiol; 2024 Jan; 186():81-93. PubMed ID: 37995517
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
11. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
[TBL] [Abstract][Full Text] [Related]
13. Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation.
Huang PP; Fu J; Liu LH; Wu KF; Liu HX; Qi BM; Liu Y; Qi BL
Int J Mol Med; 2020 Jan; 45(1):186-194. PubMed ID: 31746354
[TBL] [Abstract][Full Text] [Related]
14. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
[TBL] [Abstract][Full Text] [Related]
15. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway.
Yang HB; Lu ZY; Yuan W; Li WD; Mao S
Biol Trace Elem Res; 2022 Jun; 200(6):2848-2856. PubMed ID: 34462843
[TBL] [Abstract][Full Text] [Related]
16. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H
J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005
[TBL] [Abstract][Full Text] [Related]
19. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
[TBL] [Abstract][Full Text] [Related]
20. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells.
Huang Z; Zhuang X; Xie C; Hu X; Dong X; Guo Y; Li S; Liao X
Cell Physiol Biochem; 2016; 40(6):1578-1590. PubMed ID: 27997926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
